UNSPSC 51342313: Ganciclovir sodium

This classification denotes a purine antagonist and antiviral agent with the molecular formula C9H12N5O4.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 02L083W284, chemically known as 9-(1,3-dihydroxy-propoxymethane)guanine but more generally known as ganciclovir sodium, which bears US NIH Compound Identifier 3454. European Medicines Agency schedules Ganciclovir sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02312MIG.

Most nations, for tariff and trade purposes, schedule ganciclovir sodium under HS 29335995 and SITC 51576. As of Q4 2014, GANCICLOVIR SODIUM remains US FDA's Preferred Term for this commodity. Ganciclovir sodium bears US NLM identifiers UMLS ID C0282399 and NCI Concept Code C1588. SMILES: C1NC2C(=O)[N-]C(NC2N1COC(CO)CO)N.[NA+].

UNSPSC 51342313 Ganciclovir sodium is a Commodity code that describes a specific antiviral pharmaceutical product, but the recent state and local opportunities tagged under this code do not reflect procurement of ganciclovir itself. Instead, the sourced records show pharmaceutical procurement activity that is misaligned with the code's nominal scope — one opportunity involves doxycycline hyclate and ciprofloxacin hydrochloride tablets through a piggyback warehouse contract, and another covers naloxone and drug deactivation systems. State and local health departments and counties are the issuing bodies observed in these records, but neither opportunity is actually buying ganciclovir sodium. The code shows little relevant recent activity aligned with its stated commodity.

The geographic spread of these opportunities spans Illinois and Florida, though the limited record set and the mismatch between the code's nominal scope and actual procurement activity limit confidence in characterizing demand patterns. The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract to Chartwell Rx LLC on August 28, 2026 through the MMCAP Infuse consortium for antibiotic tablets totaling $2,999,999.11 over the contract life (Bid Number 26-482DPH-PREPD-B-53392, IFB process). Seminole County, Florida released an IFB on June 30, 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, response due July 26, 2023. Neither of these represents active demand for ganciclovir sodium procurement under this Commodity code.